Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Medifast Inc has a consensus price target of $83 based on the ratings of 3 analysts. The high is $150 issued by Jefferies on August 4, 2022. The low is $17 issued by DA Davidson on November 5, 2024. The 3 most-recent analyst ratings were released by DA Davidson on November 5, 2024, July 22, 2024, and June 5, 2024, respectively. With an average price target of $17.33 between DA Davidson, there's an implied 0.13% upside for Medifast Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Medifast (NYSE:MED) was reported by DA Davidson on November 5, 2024. The analyst firm set a price target for $17.00 expecting MED to fall to within 12 months (a possible -1.79% downside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Medifast (NYSE:MED) was provided by DA Davidson, and Medifast upgraded their neutral rating.
The last upgrade for Medifast Inc happened on November 5, 2024 when DA Davidson raised their price target to $17. DA Davidson previously had an underperform for Medifast Inc.
The last downgrade for Medifast Inc happened on June 5, 2024 when DA Davidson changed their price target from $25 to $17.5 for Medifast Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medifast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medifast was filed on November 5, 2024 so you should expect the next rating to be made available sometime around November 5, 2025.
While ratings are subjective and will change, the latest Medifast (MED) rating was a upgraded with a price target of $16.50 to $17.00. The current price Medifast (MED) is trading at is $17.31, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.